Abstract:TARGET AUDIENCE This study is expected to provide information about contrast-induced kidney injury to interventional radiologists as well as nephrologists. PURPOSE To dynamically monitor the changes of renal diffusion and oxygenation after CM administration using diffusion-weighted MR imaging (DWI) and blood oxygen level dependent (BOLD) MRI , and to observe the different MRI changes caused by isoand low-osmolar CM in vivo during a relative long period of time (18 days). METHODS Thirty male New Zealand white rabbits (body mass ranged from 2.2 to 2.5kg) were recruited, and randomly divided into 3 groups. After 8 hours fasting, 3 groups were randomly administrated iodixanol or iopromide at a dosage of 2gI/kg or an equivalent amount of 0.9% physiological saline respectively. MR scanning was performed with a clinical 3.0T imager (Magnetom Verio, Siemens, Germany) at pre-CM (baseline) and post-CM (1 hour, day 1, 3, 6, 11, 18) administration. Apparent diffusion coefficient (ADC) and R2* values of different renal compartments (cortex, outer medulla, inner medulla) were acquired using DWI and BOLD. Blood sampling and pathological examination were performed at part of the above time-points. Serum creatinine values were used to evaluate renal function. Pathological changes were assessed by Hematoxylin-Eosin and Periodic Acid-Schiff stain. RESULTS All MRI data were normalized and expressed as percentage of baseline (Figure 2). For the iodixanol group, ADC values were significantly lower than the baseline at day 1 (95.1%±4.7%), day 3 (95.4%±5.4%), day 6 (94.9%±4.9%), day18 (92.9%±4.3%) in the outer medulla and at day 6 (92.3%±6.5%) in the inner medulla (P< .05), while R2* values were significantly higher than the baseline at 1 hour (121.7%±9.8%) in the outer medulla and 1 hour (124.5%±19.1%), day 6 (129.0%± 23.0%)in the inner medulla (P< .05). For the iopromide group, no significant difference in ADC or R2* was observed between post-CM administration and the baseline. There were no significant differences of serum creatinine values within different time-points or between the two CM groups. Pathological sections showed renal tubular epithelial cells edema after day 3 without significant differences between the two CMs. DISCUSSION Contrast induced nephropathy was assessed by the standard of short-time increase of SCr , previous study 2 suggested that iso-osmolar contrast media (IOCM) has better renal tolerability compared with low-osmolar contrast media (LOCM); however it ignored the long-term incidence of renal dialysis and failure . A study performed by Liss et al 4 found that high-viscous IOCM could cause significantly more often renal failure than low-viscous LOCM in the long run, Using functional MRI, we find IOCM can induce more pronounced and persistent renal diffusion restriction and hypoxia than the LOCM, which is in line with Liss’s findings. The mechanism of our findings may contain: 1, IOCM can lower down renal blood flow for its high viscosity, this will be followed by renal hypo-perfusion and hypoxia , thus the activity of Na+-K+ ATPase will be reduced which may limit the ability of water transport function between extraand intra-cellular, finally cytotoxic edema will show up and restricted diffusion can be noticed on DWI . 2, IOCM can lead to prolonged iodine retention for its high viscosity, which in turns to longer iodine exposure and thereby more pronounced cytotoxicity to renal parenchyma. Such effect is more remarkable in medulla where is full of tubules, and it is showed in our study evidently. 3, Iopromide results in renal cells dehydration and shrinkage due to high osmotic pressure , which in our opinion would partly offset cellular edema caused by cytotoxicity, thereby reducing the impact on ADC values. What is more, because of the osmotic diuresis effect, the CM can be eliminated faster than the IOCM. In this regard, the LOCM can protect kidney potentially , which is safer than IOCM. CONCLUSION Iodixanol (IOCM) resulted in a more significant decrease of renal diffusion and oxygenation than iopromide (LOCM) did in the setting of mild dehydration. DWI and BOLD could be served as noninvasive biomarkers in monitoring the nephrotoxicity caused by CM of different osmolality. REFERENCE: 1. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003;181(6):1463-1471. 2. Aspelin P, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348(6):491-499. 3. Maioli M, et al. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 2012;125(25):3099-3107. 4. Liss P, et al. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006;70(10):1811-1817. 5. Seeliger E, et al. Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 2007;18(11):2912-2920. 6. Wang J, et al. Time course study on the effects of iodinated contrast medium on intrarenal water transport function using diffusion-weighted MRI. J Magn Reson Imaging 2012;35(5):1139-1144. 7. Galtung HK, et al. Effect of radiologic contrast media on cell volume regulation in rabbit proximal renal tubules. Acad Radiol 2001;8(5):398-404. 8. Lenhard DC, et al. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. Invest Radiol 2012;47(9):503-510.

Adverse skin reactions to iodinated x-ray contrast agents in healthy rats

Iodixanol activation of mast cells: Implications in the pathogenesis of iodixanol-induced delayed cutaneous adverse reactions

Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.

Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China

Significant Perturbation in Renal Functional Magnetic Resonance Imaging Parameters and Contrast Retention for Iodixanol Compared with Iopromide

Retrospective Analysis of Acute Adverse Reactions of 4 Iodine Contrast Agents

Post-Marketing Surveillance of the Safety Profile of Iodixanol in the Outpatient CT Setting: A Prospective, Multicenter, Observational Study of Patient Risk Factors, Adverse Reactions and Preventive Measures in 9953 Patients

Acute Adverse Events After Iodinated Contrast Agent Administration of 359,977 Injections: A Single-Center Retrospective Study

Effect of iodinated contrast media on peripheral blood mononuclear cells in terms of cell viability, cell cycle and oxidative stress in an in vitro system

Evaluation of nephrotoxicity of iso-versus low-osmolar iodine contrast media by bold and diffusion-weighted mr imaging

Renal Tolerability of Iopromide and Iodixanol in 562 Renally Impaired Patients Undergoing Cardiac Catheterisation: the Direct Study

Rate of contrast material extravasations and allergic-like reactions: effect of extrinsic warming of low-osmolality iodinated CT contrast material to 37 degrees C

Evaluation of the acute adverse reaction of contrast medium with high and moderate iodine concentration in patients undergoing computed tomography

Trends in Adverse Events After IV Administration of Contrast Media

Extrinsic Warming of Low-Osmolality Iodinated Contrast Media to 37°C Reduced the Rate of Allergic-Like Reaction

Safety and efficacy of domestic iodixanol injection in interventional neuroradiology:a multicenter clinical trial

Adverse Reactions of Iodixanol (270mg I/mL) in Coronary CT Angiography

Renal adverse effect of intravenous administration of iodixanol (270mg I/ml)

Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial

Hypersensitivity Reactions Induced by Iodinated Contrast Media in Radiological Diagnosis: A Disproportionality Analysis Based on the FAERS Database

Adverse Reactions Induced by Non-ionic Iodinated Contrast Agent in 20,418 Patients receiving CT Examination